LY2922470

DRUG2 trials

Sponsors

Eli Lilly and Company

Conditions

Diabetes Mellitus, Type 2

Phase 1

A Study of LY2922470 in Healthy Participants and Participants With Diabetes

CompletedNCT01746017

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2012-12-31End: 2013-03-31Updated: 2019-06-03

A Study of Multiple Doses of LY2922470 in Participants With Diabetes

CompletedNCT01867216

Eli Lilly and CompanyDiabetes Mellitus, Type 2

Start: 2013-06-30End: 2014-01-31Updated: 2018-07-26